Drug Screening Market Key Trends and Developments (2026-2023) | Major key players - Alere, Thermo Fisher Scientific, Drägerwerk, Labcorp, Quest Diagnostics

Market Overview:

The Global Drug Screening Market is expected to grow at a CAGR of 17.1% during the forecasting period (2024-2031).

DataM Intelligence has published a new research report on "Drug Screening Market Size 2026". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/drug-screening-market?sz

The Drug Screening Market refers to the global industry focused on the development, production, and distribution of products and services used to detect the presence of illicit drugs, prescription medications, alcohol, and other substances in biological samples such as urine, blood, saliva, and hair. It includes testing kits, analyzers, laboratory services, and rapid diagnostic devices used across workplaces, hospitals, forensic labs, sports organizations, and law enforcement to ensure safety, compliance, and regulatory adherence.

Recent Key Developments of United States:

✅ February 2026: Rising demand for rapid testing solutions grew due to stricter laws in healthcare and transportation sectors, driven by synthetic drug proliferation like fentanyl. Government initiatives, including the Global Coalition against synthetic threats, boosted market expansion.

✅ January 2026: Workplace drug testing saw emphasis on federal marijuana rescheduling and DOT-mandated fentanyl testing, alongside state cannabis law adaptations for employers. These updates reflect ongoing efforts to balance legalization trends with public safety.

✅ December 2025: California advanced policies shifting away from testing non-psychoactive cannabis metabolites, focusing on impairment-based tests to reduce discrimination against past users. This regulatory evolution supports workplace fairness while maintaining safety protocols.

✅ November 2025: SAMHSA released updated Mandatory Guidelines for Federal Workplace Drug Testing Programs on November 16 (effective July 2025), introducing new testing panels for urine and oral fluid to improve detection accuracy. These changes aim to address emerging substances and enhance federal compliance standards.

Recent Key Developments of Japan:

✅ February 2026: PMDA updated safety precautions for drugs like cytarabine, impacting screening protocols in diagnostics. A new biotechnology working group launched to bolster supply chains and financing for screening tech.

✅ January 2026: Regulatory reforms relaxed Japanese Phase I study requirements for multi-regional trials, reducing "drug lag" and enabling faster global participation. This supports efficient early-phase clinical development in drug screening contexts.

✅ December 2025: Escalating substance abuse cases and drug trafficking fueled demand for accurate, rapid screening, particularly amid rising use of virtual currencies. Market growth projected at 13.59% CAGR through 2034, emphasizing workplace and healthcare applications.

✅ November 2025: Technological advancements in high-throughput screening and mass spectrometry improved toxicology drug screening accuracy for substance abuse and forensics. These innovations enable broader substance detection at lower concentrations.

List of the Key Players in the Drug Screening Market:

Alere
Thermo Fisher Scientific
Drägerwerk
Labcorp
Quest Diagnostics
Alfa Scientific Designs
Lifeloc
MPD Inc.
Orasure
Omega Laboratories

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/drug-screening-market?sz

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Segments Covered in the Drug Screening Market:

By Product & Service Type: Analytical Instruments, Rapid Testing Devices, Consumables, Drug Screening Services.

By Sample Type: Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Other Samples.

By End User: Workplace, Criminal Justice Systems and Law Enforcement Agencies, Drug Treatment Centers, Pain Management Centers, Schools and Colleges, Hospitals, Individual Users, Drug Testing Laboratories.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=drug-screening-market

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Drug Screening manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Drug Screening in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Drug Screening Market in 2026?
◆ What is the projected growth rate of the Drug Screening Market through 2034?
◆ Who are the key players in the Drug Screening Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.